Ligand Pharmaceuticals Inc (LGND)
SBC to Revenue
21.44%
Quarterly · Period ending:
LGND SBC to Revenue
Latest reported21.44%period ending
Latest reported21.44%period ending
LGND Quarterly SBC/Revenue (0.00% → 21.44%)
Latest values, visible window
High-resolution chart · PNG
LGND sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |